Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: J Invest Dermatol. 2021 Apr 14;141(10):2533–2536.e2. doi: 10.1016/j.jid.2021.02.758

Figure 1:

Figure 1:

Cascade of care for patients with skin cancer in low and middle income countries, depicting potential losses of patients over time from provider first suspecting skin cancer to the patient achieving sustained cancer remission. For diagnostic tests only, the cost to the patient is depicted.